Elutia Inc
NASDAQ:ELUT

Watchlist Manager
Elutia Inc Logo
Elutia Inc
NASDAQ:ELUT
Watchlist
Price: 3.26 USD -4.12% Market Closed
Market Cap: 112.7m USD
Have any thoughts about
Elutia Inc?
Write Note

Elutia Inc
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Elutia Inc
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Elutia Inc
NASDAQ:ELUT
Inventory
$3.9m
CAGR 3-Years
-28%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Inventory
$4.5B
CAGR 3-Years
13%
CAGR 5-Years
18%
CAGR 10-Years
16%
Gilead Sciences Inc
NASDAQ:GILD
Inventory
$3.4B
CAGR 3-Years
27%
CAGR 5-Years
31%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Inventory
$7.4B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Inventory
$1.1B
CAGR 3-Years
48%
CAGR 5-Years
46%
CAGR 10-Years
51%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Inventory
$3B
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
38%
No Stocks Found

Elutia Inc
Glance View

Market Cap
112.7m USD
Industry
Biotechnology

Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm is a commercial-stage company that serves two markets with products based on its biomatrix platforms. The company offers a drug-eluting biologic technology: a fusion of natural biologic material and extended antibiotic release, for device implantation and soft tissue reconstruction. Its first product is CanGaroo Envelope, used for the stabilization of implantable cardiac devices, such as pacemakers and defibrillators. Its second product is SimpliDerm Acellular Dermal Matrix, used primarily in breast reconstruction following mastectomy. The company is also engaged in the development of CanGaroo RM, which adds the antibiotics rifampin and minocycline for sustained delivery directly to the surgical site. The Company’s products are used by electrophysiologists and plastic surgeons.

ELUT Intrinsic Value
5.26 USD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Elutia Inc's Inventory?
Inventory
3.9m USD

Based on the financial report for Dec 31, 2023, Elutia Inc's Inventory amounts to 3.9m USD.

What is Elutia Inc's Inventory growth rate?
Inventory CAGR 5Y
-12%

Over the last year, the Inventory growth was -62%. The average annual Inventory growth rates for Elutia Inc have been -28% over the past three years , -12% over the past five years .

Back to Top